Meta, Merck, Apple, Alphabet, Amazon, and More Stock Market Movers

We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We’ve detected you are on Internet Explorer. For the best Barrons.com e...

6 Defensive Healthcare Stocks for 2023

As investors face another uncertain year for public equities, large-cap healthcare stocks remain an attractive defensive play. They offer a shot at insulating capital from the downturn many still expe...

Black Friday Has Lost Its Punch for Retailers and the Economy

This commentary was issued recently by money managers, research firms, and market newsletter writers and has been edited by Barron’s. Black Friday Said What? Talking Points BMO Capital MarketsNo...

Big Pharma Stocks Are Breaking Out. Here Are Some Winners.

Big pharma stocks are trying to break out to new heights. They have reported more-than-satisfactory earnings and are expecting further progress on new pipelines of drugs.   These stocks had been outpe...

Bond Yields Are Finally Looking Attractive. What to Buy Now.

It has taken a historic selloff, but the bond rout may finally be winding down. Yields are also looking plump enough to be attractive again. A two-year Treasury now gets you 4.1%, a yield not seen sin...

What Stocks Are Moving Monday? Bristol Myers, Carvana, and MicroStrategy

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...

Pelosi’s Trip to Taiwan Is a Risk to More Than Just the Chip Industry

Asian stocks worked out early there is no good outcome from Nancy Pelosi’s current tour of the region. By landing in Taiwan Tuesday or Wednesday, the speaker of the House risks Chinese military retali...

FedEx’s Dividend Hike Stands Out

Text size FedEx trucks at a sorting facility Justin Sullivan/Getty Images FedEx grabbed the headlines this week for dividend announcements, declaring an increase of more than 50% to its quarterly payo...

The Days of Big Pharma Are Over. Big Biotech Is on Its Way.

W hen GlaxoSmithKline spins off its enormous division selling drugstore staples like Advil and Tums next month, it will represent more than just the latest shuffling of assets among corporate giants. ...

Turning Point Stock Doubles on Bristol Deal. What It Means for Biotech M&A.

Text size Photograph by Georges Gobet/AFP/Getty Images Turning Point Therapeutics stock has more than doubled after Bristol Myers Squibb announced that it had agreed to buy the company. It’s just the ...

Stocks Are Ready for a Bounce Higher After S&P 500 Closes Above Bear Market

Text size Dreamstime The stock market came awfully close to finishing Friday in a bear market, at least 20% off its peak in early January. Many investors would like to see it get there so Wall Street ...

AbbVie, Gilead and 4 Other Defensive Healthcare Stocks With Big Dividend Yields

Text size An AbbVie bio safety hood Courtesy of AbbVie Deep into the second quarter of the year, stocks have yet to recover, and investors are seeking safety in defensive plays. One sector that’s bene...

U.S. Stock Futures Poised for Lower Open on Monday

Stocks are poised to open lower on Monday. Michael Nagle/Bloomberg Text size Here’s what you need to know to navigate the markets today. • U.S. stocks are set to open Monday slightly down. On Sunday n...